Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Zingerone attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats

Mohammad Taghi Mansouri 1 , 2 , Hossein Rajabi Vardanjani 1 , * , Ali Asghar Hemmati 1 , Mohammad Reza Tabandeh 3 , 4 , Anahita Rezaie 5 , Marzie Pashmforosh 1 and Kambiz Ahmadi Angali 6
Authors Information
1 Department of Pharmacology, School of Pharmacy, Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Anesthesiology, Columbia University Medical center, New York, NY 10032, USA
3 Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran
4 Stem Cells and Transgenic Technology Research Center, Shahid Chamran University of Ahvaz, Ahvaz, Iran
5 Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran
6 Department of Biostatistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 28, 2019, 14 (1); e80098
  • Published Online: March 3, 2019
  • Article Type: Research Article
  • Received: June 2, 2018
  • Revised: June 20, 2018
  • Accepted: June 27, 2018
  • DOI: 10.5812/jjnpp.80098

To Cite: Mansouri M T, Rajabi Vardanjani H, Hemmati A A, Reza Tabandeh M, Rezaie A, et al. Zingerone attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats, Jundishapur J Nat Pharm Prod. 2019 ; 14(1):e80098. doi: 10.5812/jjnpp.80098.

Copyright © 2019, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Datta A, Scotton CJ, Chambers RC. Novel therapeutic approaches for pulmonary fibrosis. Br J Pharmacol. 2011;163(1):141-72. doi: 10.1111/j.1476-5381.2011.01247.x. [PubMed: 21265830]. [PubMed Central: PMC3085875].
  • 2. Kalayarasan S, Sriram N, Sudhandiran G. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta. Life Sci. 2008;82(23-24):1142-53. doi: 10.1016/j.lfs.2008.03.018. [PubMed: 18462759].
  • 3. Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: The master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325-38. doi: 10.1038/nrneph.2016.48. [PubMed: 27108839].
  • 4. Cortijo J, Cerda-Nicolas M, Serrano A, Bioque G, Estrela JM, Santangelo F, et al. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J. 2001;17(6):1228-35. doi: 10.1183/09031936.01.00049701. [PubMed: 11491169].
  • 5. Rajan I, Narayanan N, Rabindran R, Jayasree PR, Manish Kumar PR. Zingerone protects against stannous chloride-induced and hydrogen peroxide-induced oxidative DNA damage in vitro. Biol Trace Elem Res. 2013;155(3):455-9. doi: 10.1007/s12011-013-9801-x. [PubMed: 24006104].
  • 6. Cheong KO, Shin DS, Bak J, Lee C, Kim KW, Je NK, et al. Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats. Arch Pharm Res. 2016;39(2):279-91. doi: 10.1007/s12272-015-0696-2. [PubMed: 26667466].
  • 7. Safhi MM. Nephroprotective effect of zingerone against CCl4-induced renal toxicity in swiss albino mice: Molecular mechanism. Oxid Med Cell Longev. 2018;2018:2474831. doi: 10.1155/2018/2474831. [PubMed: 29636837]. [PubMed Central: PMC5831687].
  • 8. Xie X, Sun S, Zhong W, Soromou LW, Zhou X, Wei M, et al. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 2014;19(1):103-9. doi: 10.1016/j.intimp.2013.12.028. [PubMed: 24412620].
  • 9. Lee W, Hwang MH, Lee Y, Bae JS. Protective effects of zingerone on lipopolysaccharide-induced hepatic failure through the modulation of inflammatory pathways. Chem Biol Interact. 2018;281:106-10. doi: 10.1016/j.cbi.2017.12.031. [PubMed: 29289488].
  • 10. El-Bassossy HM, Al-Thubiani WS, Elberry AA, Mujallid MI, Ghareib SA, Azhar AS, et al. Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation. PLoS One. 2017;12(12). e0189074. doi: 10.1371/journal.pone.0189074. [PubMed: 29206854]. [PubMed Central: PMC5716606].
  • 11. Egger C, Cannet C, Gerard C, Jarman E, Jarai G, Feige A, et al. Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology. PLoS One. 2013;8(5). e63432. doi: 10.1371/journal.pone.0063432. [PubMed: 23667616]. [PubMed Central: PMC3646779].
  • 12. Kumar L, Chhibber S, Harjai K. Hepatoprotective effect of zingerone (4-(4-hydroxy-3-methoxyphenyl) butan-2-one) in lipopolysaccharide induced liver injury mouse model through down regulation of inflammatory mediators. Int J Pharmacogn Phytochem Res. 2014;6(2):308-14.
  • 13. Edwards CA, O'Brien WJ. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta. 1980;104(2):161-7. doi: 10.1016/0009-8981(80)90192-8. [PubMed: 7389130].
  • 14. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271-8. doi: 10.1016/0003-2697(78)90342-1. [PubMed: 655387].
  • 15. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70-7. doi: 10.1016/0003-9861(59)90090-6. [PubMed: 13650640].
  • 16. Hubner RH, Gitter W, El Mokhtari NE, Mathiak M, Both M, Bolte H, et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 2008;44(4):507-11. 514-7. doi: 10.2144/000112729. [PubMed: 18476815].
  • 17. Puglisi S, Torrisi SE, Vindigni V, Giuliano R, Palmucci S, Mule M, et al. New perspectives on management of idiopathic pulmonary fibrosis. Ther Adv Chronic Dis. 2016;7(2):108-20. doi: 10.1177/2040622315624276. [PubMed: 26977280]. [PubMed Central: PMC4772343].
  • 18. Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, et al. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol. 2003;138(6):1037-48. doi: 10.1038/sj.bjp.0705138. [PubMed: 12684259]. [PubMed Central: PMC1573750].
  • 19. Liang X, Tian Q, Wei Z, Liu F, Chen J, Zhao Y, et al. Effect of Feining on bleomycin-induced pulmonary injuries in rats. J Ethnopharmacol. 2011;134(3):971-6. doi: 10.1016/j.jep.2011.02.008. [PubMed: 21333727].
  • 20. Goudarzi M, Kalantar M, Kalantar H. The Hepatoprotective effect of gallic acid on mercuric chloride-induced liver damage in rats. Jundishapur J Nat Pharm Prod. 2017;12(4).
  • 21. Guan C, Qiao S, Lv Q, Cao N, Wang K, Dai Y, et al. Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-gamma and subsequent expression of HGF in colons. Toxicol Appl Pharmacol. 2018;343:1-15. doi: 10.1016/j.taap.2018.02.001. [PubMed: 29408570].
  • 22. Noh YH, Baek JY, Jeong W, Rhee SG, Chang TS. Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J Biol Chem. 2009;284(13):8470-7. doi: 10.1074/jbc.M808981200. [PubMed: 19176523]. [PubMed Central: PMC2659205].
  • 23. Kilic T, Ciftci O, Cetin A, Kahraman H. Preventive effect of chrysin on bleomycin-induced lung fibrosis in rats. Inflammation. 2014;37(6):2116-24. doi: 10.1007/s10753-014-9946-6. [PubMed: 24973983].
  • 24. Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-kappaB, Muc5ac, TNF-alpha and IL-1beta. Chem Biol Interact. 2015;237:151-65. doi: 10.1016/j.cbi.2015.06.019. [PubMed: 26093215].
  • 25. You XY, Xue Q, Fang Y, Liu Q, Zhang CF, Zhao C, et al. Preventive effects of Ecliptae Herba extract and its component, ecliptasaponin A, on bleomycin-induced pulmonary fibrosis in mice. J Ethnopharmacol. 2015;175:172-80. doi: 10.1016/j.jep.2015.08.034. [PubMed: 26385580].
  • 26. Rao BN, Rao BS, Aithal BK, Kumar MR. Radiomodifying and anticlastogenic effect of Zingerone on Swiss albino mice exposed to whole body gamma radiation. Mutat Res. 2009;677(1-2):33-41. doi: 10.1016/j.mrgentox.2009.05.004. [PubMed: 19463966].
  • 27. Chitra P, Saiprasad G, Manikandan R, Sudhandiran G. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-kappaB dependant TGF-beta activation: A biphasic experimental study. Toxicol Lett. 2013;219(2):178-93. doi: 10.1016/j.toxlet.2013.03.009. [PubMed: 23523906].
  • 28. Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002;83(3):111-9. doi: 10.1046/j.1365-2613.2002.00220.x. [PubMed: 12383190]. [PubMed Central: PMC2517673].
  • 29. Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax. 2004;59(1):31-8. doi: 10.1136/thx.2003.000893. [PubMed: 14694243]. [PubMed Central: PMC1758867].
  • 30. Ruscitti F, Ravanetti F, Essers J, Ridwan Y, Belenkov S, Vos W, et al. Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice. Multidiscip Respir Med. 2017;12:8. doi: 10.1186/s40248-017-0089-0. [PubMed: 28400960]. [PubMed Central: PMC5387277].
  • 31. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006;173(7):769-76. doi: 10.1164/rccm.200505-717OC. [PubMed: 16415276].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments